Literature DB >> 23197899

Novel ATP8B1 mutation in an adult male with progressive familial intrahepatic cholestasis.

Bao-Cheng Deng1, Sa Lv, Wei Cui, Rui Zhao, Xu Lu, Jian Wu, Pei Liu.   

Abstract

Progressive familial intrahepatic cholestasis type 1 is a rare disease that is characterized by low serum γ-glutamyltransferase levels due to mutation in ATP8B1. We present a 23-year-old male who experienced persistent marked pruritus for eighteen years and recurrent jaundice for thirteen years, in addition to cholestasis that eventually became fatal. Genetic sequencing studies of the entire coding (exon) sequences of ATP8B1 and ABCB11 uncovered a novel heterozygous missense 3035G>T mutation (S1012I) and a synonymous 696T>C mutation in ATP8B1. The patient's progression was associated with not only impaired familial intrahepatic cholestasis 1 (FIC1) function but also impaired bile salt export pump expression due to the impaired FIC1 function. Our findings show that patients with intermittent cholestasis can develop progressive liver disease even after several decades and require regular follow up.

Entities:  

Keywords:  ATP8B1; Bile salt export pump; Intermittent cholestasis; Novel mutation; Progressive familial intrahepatic cholestasis type 1

Mesh:

Substances:

Year:  2012        PMID: 23197899      PMCID: PMC3508648          DOI: 10.3748/wjg.v18.i44.6504

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  15 in total

1.  A patient with novel ABCB11 gene mutations with phenotypic transition between BRIC2 and PFIC2.

Authors:  Ching-Wan Lam; Ka-Ming Cheung; Man-Shan Tsui; Matthew Shu-Ching Yan; Ching-Yin Lee; Sui-Fan Tong
Journal:  J Hepatol       Date:  2005-11-02       Impact factor: 25.083

2.  ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.

Authors:  Anne Davit-Spraul; Monique Fabre; Sophie Branchereau; Christiane Baussan; Emmanuel Gonzales; Bruno Stieger; Olivier Bernard; Emmanuel Jacquemin
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

3.  Benign recurrent intrahepatic cholestasis progressing to progressive familial intrahepatic cholestasis: low GGT cholestasis is a clinical continuum.

Authors:  Nancy A M van Ooteghem; Leo W J Klomp; Gerard P van Berge-Henegouwen; Roderick H J Houwen
Journal:  J Hepatol       Date:  2002-03       Impact factor: 25.083

4.  Hepatoblastoma in a child with progressive familial intrahepatic cholestasis.

Authors:  A Richter; E Grabhorn; A Schulz; H J Schaefer; M Burdelski; R Ganschow
Journal:  Pediatr Transplant       Date:  2005-12

Review 5.  Progressive familial intrahepatic cholestasis.

Authors:  Giulia Martina Cavestro; Luca Frulloni; Elena Cerati; Luciana Andrea Ribeiro; Vincenzo Corrente; Mario Sianesi; Angelo Franzè; Francesco Di Mario
Journal:  Acta Biomed       Date:  2002

6.  Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated to mutation in ATP8B1.

Authors:  Luis Alvarez; Paloma Jara; Elena Sánchez-Sabaté; Loreto Hierro; Javier Larrauri; María C Díaz; Carmen Camarena; Angela De la Vega; Esteban Frauca; Eduardo López-Collazo; Pablo Lapunzina
Journal:  Hum Mol Genet       Date:  2004-08-18       Impact factor: 6.150

7.  A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis.

Authors:  S S Strautnieks; L N Bull; A S Knisely; S A Kocoshis; N Dahl; H Arnell; E Sokal; K Dahan; S Childs; V Ling; M S Tanner; A F Kagalwalla; A Németh; J Pawlowska; A Baker; G Mieli-Vergani; N B Freimer; R M Gardiner; R J Thompson
Journal:  Nat Genet       Date:  1998-11       Impact factor: 38.330

8.  Characterization of mutations in ATP8B1 associated with hereditary cholestasis.

Authors:  Leo W J Klomp; Julie C Vargas; Saskia W C van Mil; Ludmila Pawlikowska; Sandra S Strautnieks; Michiel J T van Eijk; Jenneke A Juijn; Carlos Pabón-Peña; Lauren B Smith; Joseph A DeYoung; Jane A Byrne; Justijn Gombert; Gerda van der Brugge; Ruud Berger; Irena Jankowska; Joanna Pawlowska; Erica Villa; A S Knisely; Richard J Thompson; Nelson B Freimer; Roderick H J Houwen; Laura N Bull
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

9.  Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.

Authors:  Wanda M P Coston; Sofia Loera; Sean K Lau; Shin Ishizawa; Zhong Jiang; Chin-Lee Wu; Yun Yen; Lawrence M Weiss; Peiguo G Chu
Journal:  Am J Surg Pathol       Date:  2008-03       Impact factor: 6.394

10.  Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity.

Authors:  Frank Chen; M Ananthanarayanan; Sukru Emre; Ezequiel Neimark; Laura N Bull; A S Knisely; Sandra S Strautnieks; Richard J Thompson; Margret S Magid; Ronald Gordon; N Balasubramanian; Frederick J Suchy; Benjamin L Shneider
Journal:  Gastroenterology       Date:  2004-03       Impact factor: 22.682

View more
  2 in total

1.  Autoinhibition and regulation by phosphoinositides of ATP8B1, a human lipid flippase associated with intrahepatic cholestatic disorders.

Authors:  Sara Abad Herrera; Michelle Juknaviciute Laursen; Thibaud Dieudonné; Maylis Lejeune; Charlott Stock; Kahina Slimani; Christine Jaxel; Joseph A Lyons; Cédric Montigny; Thomas Günther Pomorski; Poul Nissen; Guillaume Lenoir
Journal:  Elife       Date:  2022-04-13       Impact factor: 8.713

2.  New paradigms of USP53 disease: normal GGT cholestasis, BRIC, cholangiopathy, and responsiveness to rifampicin.

Authors:  Hamoud Alhebbi; Abdul Ali Peer-Zada; Abdulrahman A Al-Hussaini; Sara Algubaisi; Awad Albassami; Nasser AlMasri; Yasir Alrusayni; Ibrahim M Alruzug; Essa Alharby; Manar A Samman; Syed Zubair Ayoub; Sateesh Maddirevula; Roy W A Peake; Fowzan S Alkuraya; Sami Wali; Naif A M Almontashiri
Journal:  J Hum Genet       Date:  2020-08-06       Impact factor: 3.172

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.